CTE logo

Cryosite Limited Stock Price

ASX:CTE Community·AU$49.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

CTE Share Price Performance

AU$0
-0.80 (-100.00%)
AU$0
-0.80 (-100.00%)
Price AU$0

CTE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

1 Risk
2 Rewards

Cryosite Limited Key Details

AU$14.1m

Revenue

AU$5.2m

Cost of Revenue

AU$8.9m

Gross Profit

AU$7.0m

Other Expenses

AU$1.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.039
62.98%
13.35%
0%
View Full Analysis

About CTE

Founded
1999
Employees
25
CEO
n/a
WebsiteView website
www.cryosite.com

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements. The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage. The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls. It also offers reverse logistics services, secondary packaging, inventory management, and quality transportation and distribution solutions. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

Recent CTE News & Updates

Recent updates

No updates